TSE:MFC

Manulife Financial (MFC.TO)

57.04
+0.49 (0.87%)
as of Jun 25, 2026, 8:00:00 pm Market Open.
1634 watching
0
Investor Insights
star iconJun 25, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed opinions from market experts. Many analysts recognize MFC's potential, particularly highlighting its growth in Asia and successful capital generation from legacy businesses. The consensus seems to indicate a solid long-term investment due to its steady dividend yield, with several experts suggesting that patience may be required as the stock navigates short-term fluctuations. Despite some concerns about past performance and market positioning against competitors, the company's strategy and management is viewed positively. Analysts mention the current valuation as reasonable compared to peers, suggesting MFC is a better option for income rather than growth. Overall, there is a cautious optimism about MFC's capabilities and future direction.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
SLF-T
DON'T BUY

The reason it went down after the blowout earnings is related to the financial crisis. During the crisis, MFC almost went out of business. They totally de-risked themselves coming out of the crisis. They never benefitted from good times. The best thing for insurance companies is for interest rates go up. Prefers Sunlife, a much better company.

TOP PICK
Expecting good numbers from all the lifecos. Extremely well capitalized. Asian operations doing extremely well. Should see dividend increases and capital appreciation. Inexpensive relative to peers. Yield is 4.26%. (Analysts’ price target is $28.10)
HOLD
Their performance was not that good recently but they have decent valuation, good growth and good positioning. Financials have lagged a little recently. He thinks it is incredibly cheap here. Stick to your guns.
DON'T BUY
Could easily be over $30, or not. Long-term performance has been ugly since the financial crisis. Lack of growth, hard to understand the valuation. Interest rates rising could be a tailwind. Hard to evaluate the business quality.
WEAK BUY
It has trouble breaking $28, but he remains positive on this long term and bought shares in the low-20s. Managers are doing a good job. MFC won't be exciting, but their over 4% dividend probably will grow. Happy to own it.
BUY
When companies break down, it takes 10 years to repair the damage. A lot of investors suffer exhaustion. But this creates an opportunity for the next expansionary cycle. The whole insurance sector is attractive. Knocking on the door of making a 12-year high. Great global footprint, Chinese business, wealth management, growing earnings, nice dividend. If it trades through $28, you're going to have a pretty good ongoing rally, and this is likely with the group's tailwinds.
BUY
A core holding of his. It pays a 4% yield with strong growth in Asia. New management in recent years has reduced legacy costs holding this back. He sees good growth for MFC and is trading at a modest 9x earning this year. In 2008, they were heavily exposed to equity markets, but a lot of this is now behind them. People are unforgiving of large financials cutting their dividend, but MFC's dividend has been catching up, which he's glad to see.
BUY
People were worried about low interest rates and asset write downs. These haven't happened. Diversified business model. Environment is very strong for them, especially in Asia. Expects dividend increases. Not an expensive price to book value.
BUY

MFC vs. SLF With increasing interest rates, either makes a lot of sense right now. He owns SLF. With MFC, you get about twice the exposure to the Asian market. SLF has more exposure to Canada. MFC has more beta, higher dividend, a bit cheaper. With the Asian recovery, MFC could perform a bit better. SLF gives you more stability. SLF yield is 3.5%. MFC yield is 4.5%

BUY
They are participating in the positive sentiment on reopening. There is still upside to this whole group. She thinks this one will continue to trade higher with the broader group.
BUY
An attractive choice right now. They are starting to get over their legacy business and are trying to sell it. They have had a few good quarters. Their book value is growing since it will garner a higher valuation. Return on equity will start to improve with higher earnings. Likes their Asian presence.
BUY
Strong Asian business. If we see a couple of quarters with traction, pretty conceivable to see a 3-handle on the stock. Management doing a good job cleaning up US legacy businesses. Wealth management doing quite well. Price doesn't reflect full value of the company.
PAST TOP PICK
(A Top Pick Jan 30/20, Down 4%) They have been so desperate for a steepening yield curve. Stocks have already started to respond to this. Buying this with a dividend of 4%+ dividend yield. They are poised to rebound.
BUY ON WEAKNESS
There will be tremendous volatility with rallies when the yield curve steepens and then being hammered when the curve flattens. You must be disciplined for lifecos. Interest rates will not go up and normalize in a 5-year timeframe. Buy the dips but do not buy in strength.
BUY

MFC vs. GWO Likes Great West in his portfolio because of its strong yield of about 4.76%. MFC dividend is 4.63%. Both have performed well since March 2020. Quite similar. MFC provides more foreign exposure, especially Asia. Insurers are doing well now, and benefit from steepening yield curves.

Showing 256 to 270 of 2,281 entries